↓ Skip to main content

A CRISPR-Cas13a Based Strategy That Tracks and Degrades Toxic RNA in Myotonic Dystrophy Type 1

Overview of attention for article published in Frontiers in Genetics, December 2020
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (81st percentile)
  • High Attention Score compared to outputs of the same age and source (91st percentile)

Mentioned by

twitter
7 X users
patent
3 patents

Citations

dimensions_citation
19 Dimensions

Readers on

mendeley
35 Mendeley